Maximus Posts $8.24 Adjusted EPS, Guides FY27 to $7.50-$8.00, Closes Agile Defense
MMS sits 29% above its 52-week low of $51.036.
Summary
Maximus closed FY2026 with adjusted EPS of $8.24, above guidance, and set FY2027 guidance of $7.50-$8.00 adjusted EPS on $5.45-$5.65B revenue including the now-completed $660M Agile Defense acquisition. Free cash flow is guided to rebound to $700-$800M from just $69M.
Key Events · Earnings and Guidance · MMS
-
FY2026 Adjusted EPS Beats Guidance
Full-year revenue of $5.23B landed within the guidance range, while adjusted diluted EPS of $8.24 exceeded the top end and rose 12.0% year over year. GAAP diluted EPS was $7.27.
-
FY2027 Guidance Set at $7.50-$8.00
Revenue guided to $5.45-$5.65B and adjusted diluted EPS to $7.50-$8.00, including about ten months of Agile Defense. Guidance assumes no VA MDE incentive, versus an estimated $1.05 per share benefit in FY2026; excluding that, the midpoint implies roughly 8% growth.
-
Agile Defense Acquisition Closed
The $660M cash acquisition (plus up to $50M in earnouts) completed November 18, 2026, expanding defense and national security exposure. Pro forma leverage is expected at approximately 2.3x, within the 2x-3x target range.
-
Free Cash Flow Guided to Rebound
FY2026 free cash flow was $69M on $112M of operating cash flow, weighed down by a $442M receivables build. FY2027 guidance of $700-$800M assumes DSO returns to 60-70 days and includes more than $330M already collected from a major customer after year-end.
Analysis · MMS · Trade & Services
Full-year adjusted EPS of $8.24 came in above the top of guidance, but the number investors will focus on is FY2027: $7.50-$8.00 adjusted EPS is roughly flat to down versus FY2026 because the $1.05 per share of VA MDE incentive pay does not repeat. Management says the midpoint still represents about 8% growth excluding that incentive, and the just-closed Agile Defense deal adds roughly ten months of revenue to the $5.45-$5.65B top line. The cash flow picture is the swing factor — FY2026 free cash flow was only $69M on $112M of operating cash flow, depressed by a $442M receivables build, and guidance assumes $700-$800M as DSO normalizes to 60-70 days and the $330M already collected from a major customer lands. Pro forma leverage of about 2.3x stays inside the 2x-3x target, and the full $400M buyback authorization remains unused.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MMS was trading at $65.60 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $51.04 to $100.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.